Publicacións nas que colabora con Andrés López Muñiz (10)

2016

  1. Identification of targets for prevention of peritoneal catheter tunnel and exit-site infections in low incidence settings

    Peritoneal Dialysis International, Vol. 36, Núm. 1, pp. 43-51

  2. Inhibition of gastric acid secretion by H2 receptor antagonists associates a definite risk of enteric peritonitis and infectious mortality in patients treated with peritoneal dialysis

    PLoS ONE, Vol. 11, Núm. 2

  3. Serum levels of the adipomyokine irisin in patients with chronic kidney disease

    Nefrologia, Vol. 36, Núm. 5, pp. 496-502

2012

  1. Effect of dialysis modality and other prescription factors on peritoneal protein excretion in peritoneal dialysis

    Nefrologia, Vol. 32, Núm. 6, pp. 782-789

  2. Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 1, pp. 369-374

  3. Getting the right patient on the right renal replacement therapy

    Contributions to Nephrology, Vol. 178, pp. 40-46

2010

  1. Análisis del transporte peritoneal de potasio mediante pruebas de equilibrio peritoneal con diferentes concentraciones de glucosa

    Nefrologia, Vol. 30, Núm. 1, pp. 95-102

  2. Peritoneal protein transport during the baseline peritoneal equilibration test is an accurate predictor of the outcome of peritoneal dialysis patients

    Nephron - Clinical Practice, Vol. 116, Núm. 2

  3. Peritoneal total protein transport assessed from peritoneal equilibration tests using different dialysate glucose concentrations

    Peritoneal Dialysis International, Vol. 30, Núm. 5, pp. 549-557

2008

  1. Short-term regulation of peptide YY secretion by a mixed meal or peritoneal glucose-based dialysate in patients with chronic renal failure

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 11, pp. 3696-3703